ResourceLife Sciences
Biomarkers in Respiratory Disease: Chronic Obstructive Pulmonary Disease
16 Nov 2016This white paper highlights a potential application for LGCs Biomarker Testing Service, the monitoring of Chronic Obstructive Pulmonary Disease (COPD). The analysis of disease progression and treatment response in COPD is reliant on the triangulation of biomarkers from three sub-pathologies.
Related Products
Request Quote for All Products
Biomarker testing service
ResolianBiomarker strategy is critical to success. Our personalized biomarker solutions help drive your development to market. The expert biomarker teams support non-clinical and clinical biomarker method development, validation, and sample analysis.